These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1149 related articles for article (PubMed ID: 8039113)

  • 1. Anti-B16-F10 melanoma activity of a basic fibroblast growth factor-saporin mitotoxin.
    Ying W; Martineau D; Beitz J; Lappi DA; Baird A
    Cancer; 1994 Aug; 74(3):848-53. PubMed ID: 8039113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo.
    Beitz JG; Davol P; Clark JW; Kato J; Medina M; Frackelton AR; Lappi DA; Baird A; Calabresi P
    Cancer Res; 1992 Jan; 52(1):227-30. PubMed ID: 1309225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The basic fibroblast growth factor-saporin mitotoxin acts through the basic fibroblast growth factor receptor.
    Lappi DA; Maher PA; Martineau D; Baird A
    J Cell Physiol; 1991 Apr; 147(1):17-26. PubMed ID: 1645359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and activities of a recombinant basic fibroblast growth factor-saporin fusion protein.
    Lappi DA; Ying W; Barthelemy I; Martineau D; Prieto I; Benatti L; Soria M; Baird A
    J Biol Chem; 1994 Apr; 269(17):12552-8. PubMed ID: 8175664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saporin toxins directed to basic fibroblast growth factor receptors effectively target human ovarian teratocarcinoma in an animal model.
    Davol P; Beitz JG; Mohler M; Ying W; Cook J; Lappi DA; Frackelton AR
    Cancer; 1995 Jul; 76(1):79-85. PubMed ID: 8630880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic FGF-SAP mitotoxin in the hippocampus. Specific lethal effect on cells expressing the basic FGF receptor.
    Gonzalez AM; Lappi DA; Buscaglia ML; Carman LS; Gage FH; Baird A
    Ann N Y Acad Sci; 1991; 638():442-4. PubMed ID: 1664696
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines.
    Tetzke TA; Caton MC; Maher PA; Parandoosh Z
    Clin Exp Metastasis; 1997 Nov; 15(6):620-9. PubMed ID: 9344046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and chemical characterization of basic FGF-saporin mitotoxin.
    Lappi DA; Martineau D; Baird A
    Biochem Biophys Res Commun; 1989 Apr; 160(2):917-23. PubMed ID: 2541718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor-2-toxin induced cytotoxicity: differential sensitivity of co-cultured vascular smooth muscle cells and endothelial cells.
    Lin PH; Ren D; Hirko MK; Kang SS; Pierce GF; Greisler HP
    Atherosclerosis; 1998 Apr; 137(2):277-89. PubMed ID: 9622271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the heterogeneity of chemically conjugated targeted toxins: homogeneous basic FGF-saporin.
    Lappi DA; Matsunami R; Martineau D; Baird A
    Anal Biochem; 1993 Aug; 212(2):446-51. PubMed ID: 8214586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The basic fibroblast growth factor-saporin mitotoxin impairs in vivo skeletal regeneration following injury.
    Lefaucheur JP; Sébille A
    Neuromuscul Disord; 1993; 3(5-6):367-70. PubMed ID: 8186677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic fibroblast growth factor-saporin mitotoxin. In vitro studies of its cell-killing activity and of substances that alter that activity.
    Martineau D; Lappi DA; Amburn E; Baird A
    Ann N Y Acad Sci; 1991; 638():438-41. PubMed ID: 1785818
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibroblast growth factor complexed to the cytotoxin saporin is growth inhibitory but not cytotoxic for embryonal carcinoma cells.
    Miller K; Wilder PJ; Rizzino A
    Cytotechnology; 1993; 13(2):69-78. PubMed ID: 7764580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal model.
    Davol PA; Garza S; Frackelton AR
    Cancer; 1999 Nov; 86(9):1733-41. PubMed ID: 10547546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of a homogeneous chemical conjugate between basic fibroblast growth factor and saporin.
    Buechler YJ; Sosnowski BA; Victor KD; Parandoosh Z; Bussell SJ; Shen C; Ryder M; Houston LL
    Eur J Biochem; 1995 Dec; 234(3):706-13. PubMed ID: 8575426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic effects of basic FGF and heparin binding EGF conjugated with cytotoxin saporin on vascular cell cultures.
    Chen C; Li J; Micko CJ; Pierce GF; Cunningham MR; Lumsden AB
    J Surg Res; 1998 Feb; 75(1):35-41. PubMed ID: 9614854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective elimination of fibroblasts from pancreatic islet monolayers by basic fibroblast growth factor-saporin mitotoxin.
    Beattie GM; Lappi DA; Baird A; Hayek A
    Diabetes; 1990 Aug; 39(8):1002-5. PubMed ID: 2165003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic fibroblast growth factor in cells derived from Dupuytren's contracture: synthesis, presence, and implications for treatment of the disease.
    Lappi DA; Martineau D; Maher PA; Florkiewicz RZ; Buscaglia M; Gonzalez AM; Farris J; Hamer M; Fox R; Baird A
    J Hand Surg Am; 1992 Mar; 17(2):324-32. PubMed ID: 1314273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
    J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of human T-cell acute lymphoblastic leukaemia in severe combined immunodeficient mice with two different anti-CD7-saporin immunotoxins containing hindered or non-hindered disulphide cross-linkers.
    Flavell DJ; Boehm DA; Okayama K; Kohler JA; Flavell SU
    Int J Cancer; 1994 Aug; 58(3):407-14. PubMed ID: 7519586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.